Product Added to Cart!
9-β-D-Arabinofuranosylguanine|CS-0103409|38819-10-2

9-β-D-Arabinofuranosylguanine

$59.80

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku TS246CS-0103409_1_G
ChemScene
Get Bulk Quote

Product Information

Product Name
9-β-D-Arabinofuranosylguanine
Brand Name
ChemScene
Product Number
CS-0103409
CAS
38819-10-2
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
135499520
IUPAC Name
2-amino-9-(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl-1H-purin-6-one
InChI Key
NYHBQMYGNKIUIF-FJFJXFQQSA-N
SMILES
C1=NC2=C(N1C@H3C@H(C@@H(C@H(O3)CO)O)O)N=C(NC2=O)N

References Data Source From Pubchem

Optimization of upfront therapy for adult acute lymphoblastic leukemia: a paradigm shift toward immunotherapy
Publication Name: Medical oncology (Northwood, London, England)
Publication Date: 2025-10-22
DOI: 10.1007/s12032-025-03093-6

Nelarabine in T-cell acute lymphoblastic leukemia: intracellular metabolism and molecular mode-of-action
Publication Name: Leukemia
Publication Date: 2025-02-17
DOI: 10.1038/s41375-025-02529-2

Developments in the Fabrication of Nanomaterial-Based Voltammetric Sensors
Publication Name: Advancements in Voltammetry for Biosensing Applications
Publication Date: 2025
DOI: 10.1007/978-981-96-2595-6_6

The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades
Publication Name: Journal of Hematology & Oncology
Publication Date: 2023-03-16
DOI: 10.1186/s13045-023-01409-5

New Agents for the Treatment of T-Cell Acute Lymphoblastic Leukemia
Publication Name: Clinical Management of Acute Lymphoblastic Leukemia
Publication Date: 2022
DOI: 10.1007/978-3-030-85147-7_14